Literature DB >> 197658

The effects of methylxanthines on catecholamine-stimulated and normal chick embryos.

E F Gilbert, H J Bruyere, S Ishikawa, M O Cheung, R J Hodach.   

Abstract

Dose of theophylline and caffeine which do not produce aortic arch anomalies in embryonic chicks have been shown to potentiate catecholamine-induced aortic arch malformations in that experimental animal. Theophylline (2.1 X 10(-5) mole per milliliter isotonic saline solution) potentiated the effective dose of norepinephrine more than 100 times. The greatest potentiation observed with epinephrine (2.5 X) was induced by 2.6 X 10(-5) mole caffeine. This study also demonstrated that both methylxanthines specifically induce aneurysms of the ascending aorta and complete absence (or nearly complete constriction) of the right ductus arteriosus. The incidences of these types of cardiovascular malformations proved to be dose dependent with theophylline a more potent teratogen than caffeine. The mobilization of calcium and/or cyclic nucleotide phosphodiesterase inhibition by the methylxanthines are suggested as significant actions in the potentiation of catecholamine-induced aortic arch anomalies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197658     DOI: 10.1002/tera.1420160108

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  3 in total

1.  Light- and electron-microscopic observations of theophylline-induced aortic aneurysms in embryonic chicks.

Authors:  H Yokoyama; R Matsuoka; H J Bruyere; E F Gilbert; H Uno
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

2.  An aborted human fetus with truncus arteriosus communis--possible teratogenic effect of Tedral.

Authors:  R Matsuoka; E F Gilbert; H Bruyers; J M Optiz
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

3.  Acetylsalicylic acid-induced morphological changes in the ductus arteriosus of the chick embryo.

Authors:  S Ishikawa; M O Cheung; E F Gilbert; H J Bruyère
Journal:  Experientia       Date:  1979-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.